De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China.

Autor: Luo, Jie, Du, Xin, Lou, Jin, Wu, Jianwei, Ma, Liping, Huang, Jixian, Wang, Liangtuo, Tu, Chuanqing, Liu, Zelin, Chen, Liya, Tan, Yaxian, Luo, Dongmei, Liang, Hanyin, Yin, Changxin, Cao, Rui, Zhou, Xuan, Liu, Qifa, Liu, Xiaoli, Xu, Na
Zdroj: EJHaem; Nov2022, Vol. 3 Issue 4, p1220-1230, 11p
Databáze: Complementary Index